ArticleExperimental biology and medicine (Maywood, N.J.)2021

Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer.

Fang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.